Shockwave Medical, based in Fremont, Calif., is working to reshape interventional therapy with Lithoplasty Technology for the treatment of calcified peripheral vascular, coronary vascular and heart valve disease.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/22/16 | $45,000,000 | Series C |
Ally Bridge Group Deerfield Partners RA Capital Sectoral Asset Management Sofinnova Partners T. Rowe Price Associates Venrock | undisclosed |
| 10/10/17 | $35,000,000 | Series C Extension |
Fidelity Management & Research Company T. Rowe Price Associates | undisclosed |
